APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Velcade

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Velcade Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174045670330 December 2025199 pages

Choose your research edition.

Industry ResearchVelcade Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Velcade Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Velcade Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Velcade Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Velcade Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Velcade market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Velcade is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Velcade include Ben Venue Laboratories, Hospira, Beijing Shuanglu Pharmaceutical, Guangdong Lingnan Pharmaceutical, Sinopharm Pharmaceutical, Harbin Sanlian Pharmaceutical, XISUN, Nanjing Zhengda Tianqing Pharmaceutical and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Velcade market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Velcade and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Velcade sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Velcade market size, projected growth trends, production technologies, key applications, and end-use industries.

Velcade Segment by Company

Ben Venue Laboratories

Hospira

Beijing Shuanglu Pharmaceutical

Guangdong Lingnan Pharmaceutical

Sinopharm Pharmaceutical

Harbin Sanlian Pharmaceutical

XISUN

Nanjing Zhengda Tianqing Pharmaceutical

Johnson & Johnson

Shandong Luoxin Pharmaceutical Group

Shanxi Pude Pharmaceutical

Wuhan Renfu Pharmaceutical

Takeda

Xi'an Yangsen Pharmaceutical

Velcade Segment by Type

1.0 Mg Injection

3.5 Mg Injection

Velcade Segment by Application

Multiple Myeloma

Mantle Cell Lymphoma

Velcade Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Velcade market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Velcade and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Velcade.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Velcade market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Velcade manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Velcade in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Velcade in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Velcade Industry Trends Table 2. Velcade Industry Drivers Table 3. Velcade Industry Opportunities and Challenges Table 4. Velcade Industry Restraints Table 5. Global Velcade Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Velcade Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Velcade Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Velcade Sales Market Share by Manufacturers Table 9. Global Velcade Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Velcade Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Velcade Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Velcade Manufacturers, Product Type & Application Table 13. Global Velcade Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Velcade by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1.0 Mg Injection Table 17. Major Manufacturers of 3.5 Mg Injection Table 18. Global Velcade Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Velcade Sales by Type (2021-2026) & (K Units) Table 20. Global Velcade Sales by Type (2027-2032) & (K Units) Table 21. Global Velcade Sales Market Share by Type (2021-2026) Table 22. Global Velcade Sales Market Share by Type (2027-2032) Table 23. Global Velcade Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Velcade Revenue by Type (2021-2026) & (K Units) Table 25. Global Velcade Revenue by Type (2027-2032) & (K Units) Table 26. Global Velcade Revenue Market Share by Type (2021-2026) Table 27. Global Velcade Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Multiple Myeloma Table 29. Major Manufacturers of Mantle Cell Lymphoma Table 30. Global Velcade Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Velcade Sales by Application (2021-2026) & (K Units) Table 32. Global Velcade Sales by Application (2027-2032) & (K Units) Table 33. Global Velcade Sales Market Share by Application (2021-2026) Table 34. Global Velcade Sales Market Share by Application (2027-2032) Table 35. Global Velcade Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Velcade Revenue by Application (2021-2026) & (K Units) Table 37. Global Velcade Revenue by Application (2027-2032) & (K Units) Table 38. Global Velcade Revenue Market Share by Application (2021-2026) Table 39. Global Velcade Revenue Market Share by Application (2027-2032) Table 40. Global Velcade Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Velcade Sales by Region (2021-2026) & (K Units) Table 42. Global Velcade Sales Market Share by Region (2021-2026) Table 43. Global Velcade Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Velcade Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Velcade Sales by Country (2021-2026) & (K Units) Table 47. North America Velcade Sales by Country (2027-2032) & (K Units) Table 48. Europe Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Velcade Sales by Country (2021-2026) & (K Units) Table 50. Europe Velcade Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Velcade Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Velcade Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Velcade Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Velcade Sales by Country (2027-2032) & (K Units) Table 57. Global Velcade Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Velcade Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Velcade Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Velcade Revenue Market Share by Region (2021-2026) Table 61. Global Velcade Revenue Market Share by Region (2027-2032) Table 62. Ben Venue Laboratories Company Information Table 63. Ben Venue Laboratories Business Overview Table 64. Ben Venue Laboratories Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Ben Venue Laboratories Velcade Product Portfolio Table 66. Ben Venue Laboratories Recent Development Table 67. Hospira Company Information Table 68. Hospira Business Overview Table 69. Hospira Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hospira Velcade Product Portfolio Table 71. Hospira Recent Development Table 72. Beijing Shuanglu Pharmaceutical Company Information Table 73. Beijing Shuanglu Pharmaceutical Business Overview Table 74. Beijing Shuanglu Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Beijing Shuanglu Pharmaceutical Velcade Product Portfolio Table 76. Beijing Shuanglu Pharmaceutical Recent Development Table 77. Guangdong Lingnan Pharmaceutical Company Information Table 78. Guangdong Lingnan Pharmaceutical Business Overview Table 79. Guangdong Lingnan Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Guangdong Lingnan Pharmaceutical Velcade Product Portfolio Table 81. Guangdong Lingnan Pharmaceutical Recent Development Table 82. Sinopharm Pharmaceutical Company Information Table 83. Sinopharm Pharmaceutical Business Overview Table 84. Sinopharm Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sinopharm Pharmaceutical Velcade Product Portfolio Table 86. Sinopharm Pharmaceutical Recent Development Table 87. Harbin Sanlian Pharmaceutical Company Information Table 88. Harbin Sanlian Pharmaceutical Business Overview Table 89. Harbin Sanlian Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Harbin Sanlian Pharmaceutical Velcade Product Portfolio Table 91. Harbin Sanlian Pharmaceutical Recent Development Table 92. XISUN Company Information Table 93. XISUN Business Overview Table 94. XISUN Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. XISUN Velcade Product Portfolio Table 96. XISUN Recent Development Table 97. Nanjing Zhengda Tianqing Pharmaceutical Company Information Table 98. Nanjing Zhengda Tianqing Pharmaceutical Business Overview Table 99. Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio Table 101. Nanjing Zhengda Tianqing Pharmaceutical Recent Development Table 102. Johnson & Johnson Company Information Table 103. Johnson & Johnson Business Overview Table 104. Johnson & Johnson Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Johnson & Johnson Velcade Product Portfolio Table 106. Johnson & Johnson Recent Development Table 107. Shandong Luoxin Pharmaceutical Group Company Information Table 108. Shandong Luoxin Pharmaceutical Group Business Overview Table 109. Shandong Luoxin Pharmaceutical Group Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio Table 111. Shandong Luoxin Pharmaceutical Group Recent Development Table 112. Shanxi Pude Pharmaceutical Company Information Table 113. Shanxi Pude Pharmaceutical Business Overview Table 114. Shanxi Pude Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Shanxi Pude Pharmaceutical Velcade Product Portfolio Table 116. Shanxi Pude Pharmaceutical Recent Development Table 117. Wuhan Renfu Pharmaceutical Company Information Table 118. Wuhan Renfu Pharmaceutical Business Overview Table 119. Wuhan Renfu Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Wuhan Renfu Pharmaceutical Velcade Product Portfolio Table 121. Wuhan Renfu Pharmaceutical Recent Development Table 122. Takeda Company Information Table 123. Takeda Business Overview Table 124. Takeda Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Takeda Velcade Product Portfolio Table 126. Takeda Recent Development Table 127. Xi'an Yangsen Pharmaceutical Company Information Table 128. Xi'an Yangsen Pharmaceutical Business Overview Table 129. Xi'an Yangsen Pharmaceutical Velcade Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Xi'an Yangsen Pharmaceutical Velcade Product Portfolio Table 131. Xi'an Yangsen Pharmaceutical Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Velcade Distributors List Table 135. Velcade Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Velcade Product Image Figure 2. Global Velcade Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Velcade Market Size (2021-2032) & (US$ Million) Figure 4. Global Velcade Sales (2021-2032) & (K Units) Figure 5. Global Velcade Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Velcade Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1.0 Mg Injection Image Figure 9. 3.5 Mg Injection Image Figure 10. Global Velcade Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Velcade Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Velcade Sales Market Share by Type (2021-2032) Figure 13. Global Velcade Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Velcade Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Velcade Revenue Market Share by Type (2021-2032) Figure 16. Multiple Myeloma Image Figure 17. Mantle Cell Lymphoma Image Figure 18. Global Velcade Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Velcade Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Velcade Sales Market Share by Application (2021-2032) Figure 21. Global Velcade Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Velcade Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Velcade Revenue Market Share by Application (2021-2032) Figure 24. North America Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Velcade Sales Market Share by Country (2021-2032) Figure 26. U.S. Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Velcade Sales Market Share by Country (2021-2032) Figure 31. Germany Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Velcade Sales Market Share by Country (2021-2032) Figure 38. China Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Velcade Sales Market Share by Country (2021-2032) Figure 46. Brazil Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Velcade Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Velcade Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Velcade Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Velcade Revenue (2021-2032) & (US$ Million) Figure 57. North America Velcade Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Velcade Revenue (2021-2032) & (US$ Million) Figure 59. Europe Velcade Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Velcade Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Velcade Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Velcade Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Velcade Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Velcade Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Velcade Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1.0 Mg Injection
  • 3.5 Mg Injection
Applications
  • Multiple Myeloma
  • Mantle Cell Lymphoma
Companies covered
  • Ben Venue Laboratories
  • Hospira
  • Beijing Shuanglu Pharmaceutical
  • Guangdong Lingnan Pharmaceutical
  • Sinopharm Pharmaceutical
  • Harbin Sanlian Pharmaceutical
  • XISUN
  • Nanjing Zhengda Tianqing Pharmaceutical
  • Johnson & Johnson
  • Shandong Luoxin Pharmaceutical Group
  • Shanxi Pude Pharmaceutical
  • Wuhan Renfu Pharmaceutical
  • Takeda
  • Xi'an Yangsen Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Velcade Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Velcade Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Velcade Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Velcade Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Velcade Market Dynamics
  1. 2.1 Velcade Industry Trends
  2. 2.2 Velcade Industry Drivers
  3. 2.3 Velcade Industry Opportunities and Challenges
  4. 2.4 Velcade Industry Restraints
3 Velcade Market by Manufacturers
  1. 3.1 Global Velcade Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Velcade Sales by Manufacturers (2021-2026)
  3. 3.3 Global Velcade Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Velcade Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Velcade Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Velcade Manufacturers, Product Type & Application
  7. 3.7 Global Velcade Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Velcade Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Velcade Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Velcade Tier 1, Tier 2, and Tier 3
4 Velcade Market by Type
  1. 4.1 Velcade Type Introduction
  2. 4.1.1 1.0 Mg Injection
  3. 4.1.2 3.5 Mg Injection
  4. 4.2 Global Velcade Sales by Type
  5. 4.2.1 Global Velcade Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Velcade Sales by Type (2021-2032)
  7. 4.2.3 Global Velcade Sales Market Share by Type (2021-2032)
  8. 4.3 Global Velcade Revenue by Type
  9. 4.3.1 Global Velcade Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Velcade Revenue by Type (2021-2032)
  11. 4.3.3 Global Velcade Revenue Market Share by Type (2021-2032)
5 Velcade Market by Application
  1. 5.1 Velcade Application Introduction
  2. 5.1.1 Multiple Myeloma
  3. 5.1.2 Mantle Cell Lymphoma
  4. 5.2 Global Velcade Sales by Application
  5. 5.2.1 Global Velcade Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Velcade Sales by Application (2021-2032)
  7. 5.2.3 Global Velcade Sales Market Share by Application (2021-2032)
  8. 5.3 Global Velcade Revenue by Application
  9. 5.3.1 Global Velcade Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Velcade Revenue by Application (2021-2032)
  11. 5.3.3 Global Velcade Revenue Market Share by Application (2021-2032)
6 Global Velcade Sales by Region
  1. 6.1 Global Velcade Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Velcade Sales by Region (2021-2032)
  3. 6.2.1 Global Velcade Sales by Region (2021-2026)
  4. 6.2.2 Global Velcade Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Velcade Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Velcade Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Velcade Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Velcade Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Velcade Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Velcade Revenue by Region
  1. 7.1 Global Velcade Revenue by Region
  2. 7.1.1 Global Velcade Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Velcade Revenue by Region (2021-2026)
  4. 7.1.3 Global Velcade Revenue by Region (2027-2032)
  5. 7.1.4 Global Velcade Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Velcade Revenue (2021-2032)
  8. 7.2.2 North America Velcade Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Velcade Revenue (2021-2032)
  11. 7.3.2 Europe Velcade Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Velcade Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Velcade Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Velcade Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Velcade Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ben Venue Laboratories
  2. 8.1.1 Ben Venue Laboratories Company Information
  3. 8.1.2 Ben Venue Laboratories Business Overview
  4. 8.1.3 Ben Venue Laboratories Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ben Venue Laboratories Velcade Product Portfolio
  6. 8.1.5 Ben Venue Laboratories Recent Developments
  7. 8.2 Hospira
  8. 8.2.1 Hospira Company Information
  9. 8.2.2 Hospira Business Overview
  10. 8.2.3 Hospira Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hospira Velcade Product Portfolio
  12. 8.2.5 Hospira Recent Developments
  13. 8.3 Beijing Shuanglu Pharmaceutical
  14. 8.3.1 Beijing Shuanglu Pharmaceutical Company Information
  15. 8.3.2 Beijing Shuanglu Pharmaceutical Business Overview
  16. 8.3.3 Beijing Shuanglu Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Beijing Shuanglu Pharmaceutical Velcade Product Portfolio
  18. 8.3.5 Beijing Shuanglu Pharmaceutical Recent Developments
  19. 8.4 Guangdong Lingnan Pharmaceutical
  20. 8.4.1 Guangdong Lingnan Pharmaceutical Company Information
  21. 8.4.2 Guangdong Lingnan Pharmaceutical Business Overview
  22. 8.4.3 Guangdong Lingnan Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guangdong Lingnan Pharmaceutical Velcade Product Portfolio
  24. 8.4.5 Guangdong Lingnan Pharmaceutical Recent Developments
  25. 8.5 Sinopharm Pharmaceutical
  26. 8.5.1 Sinopharm Pharmaceutical Company Information
  27. 8.5.2 Sinopharm Pharmaceutical Business Overview
  28. 8.5.3 Sinopharm Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sinopharm Pharmaceutical Velcade Product Portfolio
  30. 8.5.5 Sinopharm Pharmaceutical Recent Developments
  31. 8.6 Harbin Sanlian Pharmaceutical
  32. 8.6.1 Harbin Sanlian Pharmaceutical Company Information
  33. 8.6.2 Harbin Sanlian Pharmaceutical Business Overview
  34. 8.6.3 Harbin Sanlian Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Sanlian Pharmaceutical Velcade Product Portfolio
  36. 8.6.5 Harbin Sanlian Pharmaceutical Recent Developments
  37. 8.7 XISUN
  38. 8.7.1 XISUN Company Information
  39. 8.7.2 XISUN Business Overview
  40. 8.7.3 XISUN Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 XISUN Velcade Product Portfolio
  42. 8.7.5 XISUN Recent Developments
  43. 8.8 Nanjing Zhengda Tianqing Pharmaceutical
  44. 8.8.1 Nanjing Zhengda Tianqing Pharmaceutical Company Information
  45. 8.8.2 Nanjing Zhengda Tianqing Pharmaceutical Business Overview
  46. 8.8.3 Nanjing Zhengda Tianqing Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Zhengda Tianqing Pharmaceutical Velcade Product Portfolio
  48. 8.8.5 Nanjing Zhengda Tianqing Pharmaceutical Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Velcade Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Shandong Luoxin Pharmaceutical Group
  56. 8.10.1 Shandong Luoxin Pharmaceutical Group Company Information
  57. 8.10.2 Shandong Luoxin Pharmaceutical Group Business Overview
  58. 8.10.3 Shandong Luoxin Pharmaceutical Group Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Luoxin Pharmaceutical Group Velcade Product Portfolio
  60. 8.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  61. 8.11 Shanxi Pude Pharmaceutical
  62. 8.11.1 Shanxi Pude Pharmaceutical Company Information
  63. 8.11.2 Shanxi Pude Pharmaceutical Business Overview
  64. 8.11.3 Shanxi Pude Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanxi Pude Pharmaceutical Velcade Product Portfolio
  66. 8.11.5 Shanxi Pude Pharmaceutical Recent Developments
  67. 8.12 Wuhan Renfu Pharmaceutical
  68. 8.12.1 Wuhan Renfu Pharmaceutical Company Information
  69. 8.12.2 Wuhan Renfu Pharmaceutical Business Overview
  70. 8.12.3 Wuhan Renfu Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Wuhan Renfu Pharmaceutical Velcade Product Portfolio
  72. 8.12.5 Wuhan Renfu Pharmaceutical Recent Developments
  73. 8.13 Takeda
  74. 8.13.1 Takeda Company Information
  75. 8.13.2 Takeda Business Overview
  76. 8.13.3 Takeda Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takeda Velcade Product Portfolio
  78. 8.13.5 Takeda Recent Developments
  79. 8.14 Xi'an Yangsen Pharmaceutical
  80. 8.14.1 Xi'an Yangsen Pharmaceutical Company Information
  81. 8.14.2 Xi'an Yangsen Pharmaceutical Business Overview
  82. 8.14.3 Xi'an Yangsen Pharmaceutical Velcade Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Xi'an Yangsen Pharmaceutical Velcade Product Portfolio
  84. 8.14.5 Xi'an Yangsen Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Velcade Value Chain Analysis
  2. 9.1.1 Velcade Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Velcade Production Mode & Process
  6. 9.2 Velcade Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Velcade Distributors
  9. 9.2.3 Velcade Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst